Clinical Trial Update: Endothelial Progenitor Cells and Risk Factors for Coronary Artery Disease

View source ↗

Summary

An NHLBI-sponsored clinical trial investigating endothelial progenitor cells and their relationship to risk factors for coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Coronary Arteriosclerosis | Status: COMPLETED